 |
27 Diseases |  |
22 Trials |
|
22 Trials |  |
341 News |  |
| «1234567» |
- | NN1213 / Novo Nordisk
Trial completion: Maintenance Treatment for Abstinent Smokers (clinicaltrials.gov) - Jan 11, 2017
P3, N=589, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Completed
- | bupropion sustained-release / Generic mfg., methadone / Generic mfg.
Trial completion: Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients (clinicaltrials.gov) - Jan 11, 2017
P2, N=28, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Completed No longer recruiting --> Completed
- bupropion sustained-release / Generic mfg.
New trial: Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking (clinicaltrials.gov) - Dec 19, 2016
P=N/A, N=10, Recruiting, Sponsor: Duke University
- Chantix (varenicline) / Pfizer
New trial: Treating Smokeless Tobacco Use in Rural Veterans (clinicaltrials.gov) - Dec 15, 2016
P=N/A, N=50, Not yet recruiting, Sponsor: University of Iowa
- Chantix (varenicline) / Pfizer
Trial completion, Enrollment change, Trial primary completion date: Tailored Tobacco Quitline for Rural Veterans (clinicaltrials.gov) - Dec 9, 2016
P2, N=63, Completed, Sponsor: University of Iowa
No longer recruiting --> Completed Enrolling by invitation --> Completed | N=50 --> 63 | Trial primary completion date: Sep 2012 --> Jun 2013
- | Chantix (varenicline) / Pfizer
Enrollment closed, Trial primary completion date: Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers (clinicaltrials.gov) - Dec 8, 2016
P3, N=411, Active, not recruiting, Sponsor: University of Iowa
Enrolling by invitation --> Completed | N=50 --> 63 | Trial primary completion date: Sep 2012 --> Jun 2013 Not yet recruiting --> Active, not recruiting | Trial primary completion date: Oct 2017 --> Dec 2016
- bupropion sustained-release / Generic mfg.
Enrollment closed: CPT and Smoking Cessation (clinicaltrials.gov) - Dec 5, 2016
P2/3, N=50, Active, not recruiting, Sponsor: VA Office of Research and Development
Not yet recruiting --> Active, not recruiting | Trial primary completion date: Oct 2017 --> Dec 2016 Recruiting --> Active, not recruiting
- bupropion sustained-release / Generic mfg.
Trial initiation date: Smoking Treatment and Exercise Program for Underserved Populations (STEP UP) (clinicaltrials.gov) - Nov 9, 2016
P=N/A, N=10, Not yet recruiting, Sponsor: Duke University
Recruiting --> Active, not recruiting Initiation date: Sep 2016 --> Dec 2016
- bupropion sustained-release / Generic mfg., fluoxetine / Generic mfg.
Trial primary completion date: Bupropion for Depression in ESRD Patients on Hemodialysis (clinicaltrials.gov) - Sep 27, 2016
P4, N=40, Recruiting, Sponsor: University of Arkansas
Initiation date: Sep 2016 --> Dec 2016 Trial primary completion date: Aug 2016 --> Aug 2017
- bupropion sustained-release / Generic mfg.
Trial primary completion date: Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking (clinicaltrials.gov) - Sep 23, 2016
P2/3, N=72, Terminated, Sponsor: National Institute on Drug Abuse (NIDA)
Trial primary completion date: Aug 2016 --> Aug 2017 Trial primary completion date: May 2008 --> Aug 2007
- lithium carbonate ER / Generic mfg.
New trial, HEOR: Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies (clinicaltrials.gov) - Sep 8, 2016
P=N/A, N=1000000, Not yet recruiting, Sponsor: University of New Mexico
- bupropion sustained-release / Generic mfg.
New trial: Smoking Treatment and Exercise Program for Underserved Populations (STEP UP) (clinicaltrials.gov) - Aug 18, 2016
P=N/A, N=10, Not yet recruiting, Sponsor: Duke University
- bupropion sustained-release / Generic mfg.
New trial: Mobile Contingency Management for Marijuana and Tobacco Cessation (clinicaltrials.gov) - Aug 17, 2016
P=N/A, N=10, Not yet recruiting, Sponsor: Duke University
- bupropion sustained-release / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Bupropion for Smoking Cessation During Pregnancy (clinicaltrials.gov) - Aug 10, 2016
P4, N=65, Completed, Sponsor: The University of Texas Medical Branch, Galveston
Trial primary completion date: May 2008 --> Aug 2007 Active, not recruiting --> Completed | N=150 --> 65 | Trial primary completion date: Dec 2016 --> Jul 2016
- Enrollment open, Trial initiation date: Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects (clinicaltrials.gov) - Jun 28, 2016
P4, N=126, Recruiting, Sponsor: Centre hospitalier de l'Universit
Active, not recruiting --> Completed | N=150 --> 65 | Trial primary completion date: Dec 2016 --> Jul 2016 Not yet recruiting --> Recruiting | Initiation date: Nov 2014 --> Apr 2015
- Chantix (varenicline) / Pfizer
Trial primary completion date, Real-world evidence, Real-world effectiveness, Real-world: The MATCH (Medication Aids for Tobacco Cessation and Health) Study (clinicaltrials.gov) - Jun 13, 2016
P=N/A, N=1500, Recruiting, Sponsor: Centre for Addiction and Mental Health
Not yet recruiting --> Recruiting | Initiation date: Nov 2014 --> Apr 2015 Trial primary completion date: Sep 2016 --> Dec 2016
- bupropion sustained-release / Generic mfg.
Trial primary completion date: Bupropion for Smoking Cessation During Pregnancy (clinicaltrials.gov) - May 13, 2016
P4, N=150, Active, not recruiting, Sponsor: The University of Texas Medical Branch, Galveston
Trial primary completion date: Sep 2016 --> Dec 2016 Trial primary completion date: Feb 2016 --> Dec 2016
- ||| bupropion sustained-release / Generic mfg.
Trial completion, Trial primary completion date: Effects of Bupropion in Depression (clinicaltrials.gov) - May 12, 2016
P=N/A, N=80, Completed, Sponsor: University of Oxford
Trial primary completion date: Feb 2016 --> Dec 2016 Recruiting --> Completed | Trial primary completion date: Jan 2016 --> May 2016
- Chantix (varenicline) / Pfizer
Enrollment closed, Trial primary completion date: Randomized Clinical Trial to Reduce Harm From Tobacco (clinicaltrials.gov) - May 11, 2016
P=N/A, N=6000, Active, not recruiting, Sponsor: University of Pennsylvania
Recruiting --> Completed | Trial primary completion date: Jan 2016 --> May 2016 Not yet recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Oct 2016
- Chantix (varenicline) / Pfizer
New trial: EsCAPE2: Effect of Smoking Cessation on Clinical and Microbiological Outcomes of the Non-surgical Periodontal Therapy (clinicaltrials.gov) - Apr 20, 2016
P=N/A, N=63, Completed, Sponsor: Claudio Mendes Pannuti
- |||| Chantix (varenicline) / Pfizer
Trial primary completion date: Combining Varenicline and Bupropion for Smoking Cessation (clinicaltrials.gov) - Apr 14, 2016
P3, N=385, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Oct 2016 Trial primary completion date: Aug 2016 --> Aug 2017
- bupropion ER / Generic mfg.
Trial completion, Surgery, Bariatric surgery: A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery (clinicaltrials.gov) - Apr 7, 2016
P4, N=20, Completed, Sponsor: North Dakota State University
Trial primary completion date: Aug 2016 --> Aug 2017 Active, not recruiting --> Completed
- NN1213 / Novo Nordisk
Trial completion: Maintaining Abstinence in Chronic Cigarette Smokers - 1 (clinicaltrials.gov) - Mar 30, 2016
P2, N=407, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Chantix (varenicline) / Pfizer
Trial primary completion date: The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior (clinicaltrials.gov) - Feb 11, 2016
P2, N=60, Active, not recruiting, Sponsor: Yale University
Active, not recruiting --> Completed Trial primary completion date: Jan 2016 --> Jul 2016
- Chantix (varenicline) / Pfizer
Biomarker, Trial primary completion date: Pharmacogenetics, Emotional Reactivity and Smoking (clinicaltrials.gov) - Feb 3, 2016
P2/3, N=375, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Jan 2016 --> Jul 2016 Trial primary completion date: Dec 2016 --> Dec 2017
- Chantix (varenicline) / Pfizer
Enrollment open: Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy (clinicaltrials.gov) - Jan 28, 2016
P=N/A, N=60, Recruiting, Sponsor: Comprehensive Cancer Center of Wake Forest University
Trial primary completion date: Dec 2016 --> Dec 2017 Not yet recruiting --> Recruiting
- Chantix (varenicline) / Pfizer
Trial primary completion date: The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior (clinicaltrials.gov) - Dec 15, 2015
P2, N=60, Active, not recruiting, Sponsor: Yale University
Not yet recruiting --> Recruiting Trial primary completion date: Sep 2015 --> Jan 2016
- bupropion sustained-release / Generic mfg.
Enrollment closed: Bupropion for Smoking Cessation During Pregnancy (clinicaltrials.gov) - Dec 5, 2015
P4, N=150, Active, not recruiting, Sponsor: The University of Texas Medical Branch, Galveston
Trial primary completion date: Sep 2015 --> Jan 2016 Recruiting --> Active, not recruiting
- Chantix (varenicline) / Pfizer
Trial primary completion date, Real-world evidence, Real-world effectiveness, Real-world: The MATCH (Medication Aids for Tobacco Cessation and Health) Study (clinicaltrials.gov) - Nov 16, 2015
P=N/A, N=1500, Recruiting, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Active, not recruiting Trial primary completion date: Sep 2015 --> Sep 2016
- | bupropion sustained-release / Generic mfg.
New P2 trial: Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men (clinicaltrials.gov) - Nov 2, 2015
P2, N=70, Recruiting, Sponsor: University of Malaya
- Chantix (varenicline) / Pfizer
New trial: Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=60, Not yet recruiting, Sponsor: Comprehensive Cancer Center of Wake Forest University
- bupropion sustained-release / Generic mfg., fluoxetine / Generic mfg.
Trial primary completion date: Bupropion for Depression in ESRD Patients on Hemodialysis (clinicaltrials.gov) - Sep 24, 2015
P4, N=40, Recruiting, Sponsor: University of Arkansas
Trial primary completion date: Sep 2015 --> Sep 2016 Trial primary completion date: Aug 2015 --> Aug 2016
- bupropion sustained-release / Generic mfg.
Trial completion, Enrollment change: QUIT4EVER: Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD (clinicaltrials.gov) - Sep 10, 2015
P=N/A, N=15, Completed, Sponsor: Duke University
Trial primary completion date: Aug 2015 --> Aug 2016 Active, not recruiting --> Completed | N=30 --> 15
- | Amenalief (amenamevir) / Maruho
Trial completion, Trial primary completion date: Drug-Drug Interaction Study: ASP2151 and Bupropion (clinicaltrials.gov) - Aug 19, 2015
P1, N=24, Completed, Sponsor: Maruho Europe Limited
Active, not recruiting --> Completed | N=30 --> 15 Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Apr 2015
- |||| Chantix (varenicline) / Pfizer
Trial completion: Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (clinicaltrials.gov) - Aug 14, 2015
P4, N=4605, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Apr 2015 No Longer Available --> Completed
- ||||||| Chantix (varenicline) / Pfizer
Trial completion, Enrollment change, Trial primary completion date: ConNicBrain: Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation (clinicaltrials.gov) - Jul 15, 2015
P3, N=282, Completed, Sponsor: Duke University
No Longer Available --> Completed Active, not recruiting --> Completed | N=1000 --> 282 | Trial primary completion date: May 2015 --> Dec 2013
- bupropion sustained-release / Generic mfg.
Trial primary completion date, Real-world evidence, Real-world effectiveness, Real-world: STOP Study: Effectiveness of Zyban in a Clinical Population (clinicaltrials.gov) - Jun 16, 2015
P4, N=750, Active, not recruiting, Sponsor: Centre for Addiction and Mental Health
Active, not recruiting --> Completed | N=1000 --> 282 | Trial primary completion date: May 2015 --> Dec 2013 Trial primary completion date: Mar 2015 --> Mar 2016
- | bupropion sustained-release / Generic mfg.
Trial completion, Trial primary completion date: Contingency Management for Smoking Cessation in Homeless Smokers (clinicaltrials.gov) - Jun 12, 2015
P=N/A, N=25, Completed, Sponsor: Duke University
Trial primary completion date: Mar 2015 --> Mar 2016 Suspended --> Completed | Trial primary completion date: Dec 2015 --> Sep 2014
- Amenalief (amenamevir) / Maruho
Trial primary completion date: Drug-Drug Interaction Study: ASP2151 and Bupropion (clinicaltrials.gov) - Jun 11, 2015
P1, N=24, Active, not recruiting, Sponsor: Maruho Europe Limited
Suspended --> Completed | Trial primary completion date: Dec 2015 --> Sep 2014 Trial primary completion date: Apr 2015 --> Jul 2015
- bupropion sustained-release / Generic mfg.
Trial primary completion date: QUIT4EVER: Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=30, Active, not recruiting, Sponsor: Duke University
Trial primary completion date: Apr 2015 --> Jul 2015 Trial primary completion date: May 2015 --> Aug 2015
- bupropion sustained-release / Generic mfg.
Trial primary completion date: Bupropion for Smoking Cessation During Pregnancy (clinicaltrials.gov) - Jun 11, 2015
P4, N=150, Recruiting, Sponsor: The University of Texas Medical Branch, Galveston
Trial primary completion date: May 2015 --> Aug 2015 Trial primary completion date: Apr 2015 --> Dec 2015
- Biomarker, Trial primary completion date: PG: Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=1000, Recruiting, Sponsor: Samsung Medical Center
Trial primary completion date: Apr 2015 --> Dec 2015 Trial primary completion date: Mar 2008 --> Dec 2016
- bupropion sustained-release / Generic mfg.
Trial termination: Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia (clinicaltrials.gov) - Jun 11, 2015
P4, N=17, Terminated, Sponsor: Massachusetts General Hospital
Trial primary completion date: Mar 2008 --> Dec 2016 Completed --> Terminated
- | aripiprazole / Generic mfg., bupropion sustained-release / Generic mfg.
Enrollment closed: VAST-D: VA Augmentation and Switching Treatments for Improving Depression Outcomes (clinicaltrials.gov) - May 29, 2015
P3, N=1518, Active, not recruiting, Sponsor: Department of Veterans Affairs
Completed --> Terminated Recruiting --> Active, not recruiting
- bupropion ER / Generic mfg.
Enrollment closed, Surgery, Bariatric surgery: A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery (clinicaltrials.gov) - May 12, 2015
P4, N=20, Active, not recruiting, Sponsor: North Dakota State University
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- bupropion sustained-release / Generic mfg., fluoxetine / Generic mfg.
Enrollment open, Trial initiation date: Bupropion for Depression in ESRD Patients on Hemodialysis (clinicaltrials.gov) - May 8, 2015
P4, N=40, Recruiting, Sponsor: University of Arkansas
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> Jan 2015
- | Chantix (varenicline) / Pfizer
Enrollment open, Trial initiation date: Web-based Smoking Cessation Program for Tribal College Students (clinicaltrials.gov) - May 5, 2015
P3, N=300, Recruiting, Sponsor: Won Choi, PhD, MPH
Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> Jan 2015 Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> May 2015
- bupropion sustained-release / Generic mfg.
New trial: Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia (clinicaltrials.gov) - Apr 17, 2015
P=N/A, N=36, Not yet recruiting, Sponsor: Duke University
- Amenalief (amenamevir) / Maruho
Enrollment closed: Drug-Drug Interaction Study: ASP2151 and Bupropion (clinicaltrials.gov) - Mar 27, 2015
P1, N=24, Active, not recruiting, Sponsor: Maruho Europe Limited
Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> May 2015 Recruiting --> Active, not recruiting
- | Amenalief (amenamevir) / Maruho
New P1 trial: Drug-Drug Interaction Study: ASP2151 and Bupropion (clinicaltrials.gov) - Feb 23, 2015
P1, N=24, Recruiting, Sponsor: Maruho Europe Limited